Reverse DCF

Hindustan Unilever: what the price is assuming

A normal DCF asks you to guess growth. Run backwards, it takes today's price and solves for the growth the market has already priced in — then you can judge whether this company can deliver it.

What the price assumes

Expensive

To justify its price of ₹1927, this stock must grow earnings at 12% every year for 7 years. Our analysis caps realistic growth at ~5%. At that growth it is worth ₹1181 — downside of 39%.

Growth the price implies
12.0% a year
for 7 years, fading to 5%
It has actually compounded at
3.3% a year
net profit, FY23–FY26 · EPS 3.4%
The gap
0.1 pp
-39% downside if it only repeats history
Price today ₹1,927 Value at the reference growth ₹1,180.97
Why this baseline, and what it is built on

Hindustan Unilever shows stable financials, but recent TTM sales growth is low at 1.81%. The promise track record is good, with many achieved promises, though some were ghosted. Management guides for FY27 to be 'better than FY26' and prioritizes 'volume-led growth', while maintaining an EBITDA margin of 22.5-23.5%. Given the stable FMCG industry, good track record, but vague growth guidance and low recent TTM growth, a conservative g1 of 5.0% is chosen, anticipating a recovery in volume growth. Very low leverage and industry stability support a low discount rate of 9%. A longer 7-year stage-1 growth period with a 4-year fade to a 5% terminal growth rate is appropriate for a mature, market-leading FMCG player.

Through 2026-03-31

Your assumptions

Change any of these and the value moves. A valuation that flips on a one-point change in the required return is telling you something.

Value on these assumptions

₹1,179.49

Against today's price

-39%

11 projected years, then a terminal value at 5.0%.

Normalized net profit is discounted as a proxy for owner earnings, not full free cash flow. An analytical tool, not investment advice.

How to read this valuation

  1. Start from the price, not the forecast. A normal DCF asks you to guess growth and hands back a fair value. Run backwards, it takes today's price and solves for the earnings growth the market is already assuming.
  2. Compare that with what the company has done. The historical profit and EPS CAGR sit beside the implied number. A price that needs 25% a year from a business that has compounded at 10% is asking a lot, and the gap is the risk you are taking on.
  3. Then apply your own view. Change the growth rate, how long it lasts, how it fades and the return you require. A valuation that flips on a one-point change in the discount rate is telling you something about itself.
  4. Mind the caveats. Normalized net profit stands in for owner earnings, not full free cash flow; terminal growth is capped at 6%, roughly nominal GDP; cyclicals are flagged because a peak-earnings base overstates value. This is an analytical tool, not investment advice.